Opendata, web and dolomites

ONCORELIEF SIGNED

A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ONCORELIEF project word cloud

Explore the words cloud of the ONCORELIEF project. It provides you a very rough idea of what is the project "ONCORELIEF" about.

drug    despite    wellness    follow    safeguard    globally    big    sciences    active    status    guardian    interdisciplinary    qol    knowhow    integration    methodology    detection    regarding    survivors    radiotherapy    personalized    patients    therapy    ultimately    assistant    modalities    immunotherapy    builds    overcome    smart    angel    suggest    ai    improvements    digital    proms    skills    centered    rising    leverage    combined    burden    18    million    physical    chemotherapy    psychosocial    action    prems    methodologically    targeted    decades    instruments    incidence    oncorelief    2018    journey    intuitive    skillfully    deaths    post    industry    thinking    treatment    36    surgery    cancer    engaged    care    brings    actions    therapeutic    datasets    treatments    health    foreseeable    occupational    prolonged    consequence    sequelae    up    period    reached    survival    drivers    technological    psychology    introducing    destructive    wellbeing   

Project "ONCORELIEF" data sheet

The following table provides information about the project.

Coordinator
EXUS SOFTWARE LTD 

Organization address
address: OLD BROAD STREET 25 TOWER 42
city: LONDON
postcode: EC2N 1PB
website: www.exus.co.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 4˙872˙250 €
 EC max contribution 4˙872˙250 € (100%)
 Programme 1. H2020-EU.3.1.5.1. (Improving halth information and better use of health data)
2. H2020-EU.3.1.3.2. (Transferring knowledge to clinical practice and scalable innovation actions)
 Code Call H2020-SC1-DTH-2019
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2022-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EXUS SOFTWARE LTD UK (LONDON) coordinator 701˙250.00
2    MCS DATALABS DE (Berlin) participant 615˙750.00
3    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) participant 461˙250.00
4    CARE ACROSS LTD UK (LONDON) participant 418˙750.00
5    MAGGIOLI SPA IT (SANTARCANGELO DI ROMAGNA) participant 409˙375.00
6    SUITE5 DATA INTELLIGENCE SOLUTIONS LIMITED CY (LIMASSOL) participant 406˙875.00
7    UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ DE (Mainz) participant 378˙375.00
8    INNOSYSTEMS SYMVOULEUTIKES YPIRESIES KAI EFARMOGES PLIROFORIKIS YPSILIS TECHNOLOGIAS MONOPROSOPI IDIOTIKI KEFALAIOUCHIKI ETAIREIA EL (ATHINA) participant 368˙750.00
9    ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS EL (THERMI THESSALONIKI) participant 256˙250.00
10    ISTITUTO SCIENTIFICO ROMAGNOLO PERLO STUDIO E LA CURA DEI TUMORI SRL IT (MELDOLA) participant 247˙500.00
11    FCIENCIAS.ID - ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS PT (LISBON) participant 221˙875.00
12    TIME.LEX BE (BRUSSEL) participant 205˙000.00
13    ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA IT (BOLOGNA) participant 181˙250.00

Map

 Project objective

The burden of cancer is rising globally and is estimated to have reached 18.1 million new cases and 9.6 million cancer deaths in 2018. Despite the rising cancer incidence, improvements in early detection and therapeutic treatment have improved cancer survival. As a consequence, the number of cancer survivors is increasing globally, creating the need to improve not only treatment but also wellness and follow‐up care. Cancer treatment often involves combined modalities such as surgery, chemotherapy, and radiotherapy. In the past decades, more effective and targeted therapeutic modalities and less destructive cancer treatments have been developed such as immunotherapy and drug‐targeted therapy. Even so, cancer and its treatment have important physical and psychosocial sequelae. ONCORELIEF is a 36-month action that will leverage the above 6 drivers in order to skillfully and methodologically overcome technical challenges, by introducing new approaches that will allow the utilization of big datasets in order to develop a user-centered AI System to facilitate the integration of QoL assessment instruments through the use of PROMs and PREMs in order to improve post-treatment health status, increase the wellbeing, and follow‐up care of cancer patients. This will be achieved through an intuitive smart digital assistant (Guardian Angel), able to provide personalized support in post-treatment activities and tasks, suggest actions regarding the patients' overall health-status, improved wellbeing and active health-care and ultimately maintain him/her engaged on a wellness journey that will safeguard his/her health over the foreseeable prolonged post-cancer treatment period. To achieve this, ONCORELIEF builds on the combined knowhow of its interdisciplinary industry-driven consortium that brings together state-of-the-art technological skills, design thinking methodology and occupational psychology/health sciences.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ONCORELIEF" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ONCORELIEF" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.5.1.;H2020-EU.3.1.3.2.)

CAPABLE (2020)

CAncer PAtients Better Life Experience

Read More  

LifeChamps (2019)

A Collective Intelligence Platform to Support Cancer Champions

Read More  

ASCAPE (2020)

Artificial intelligence Supporting CAncer Patients across Europe

Read More